Education May Help End-Stage Renal Disease Patients to Avoid Hyperphosphatemia

A cluster randomized controlled trial shows that educating patients with ESRD to avoid food additives containing phosphorus results in modest improvements in hyperphosphatemia. Medscape Medical News

Phase 1 Trial of Quadramet in Combination with Velcade Shows Positive Results

Quadramet (153 Samarium-lexidronam) is a radioactive medication that targets the bone, specifically bone cancer, and is used to treat pain caused by cancer that has metastasized or spread to the bone.

Novel economical blood test for hepatitis C

A novel blood test could bring a breakthrough in the battle against the dangerous hepatitis-C virus.

UNC study hints at new approaches to prevent transplant rejection

To prevent the rejection of newly transplanted organs and cells, patients must take medicines that weaken their entire immune systems.

Video: Zometa(R) Reduces Risk of Breast Cancer Recurrence in Premenopausal Women, Study in The New England Journal of Medicine Reports

A newly published study in The New England Journal of Medicine shows that in premenopausal women with early breast cancer administering Zometa(R) (zoledronic acid) along with post-surgery hormone therapy provided a reduction in risk of recurrence or death that was 36% beyond that achieved with hormone therapy alone(1).

Exercise lowers risk of colon cancer

An ambitious new study has added considerable weight to the claim that exercise can lower the risk for colon cancer.

Discovery of metabolite linked to aggressive prostate cancer

Researchers from the University of Michigan Comprehensive Cancer Center have identified a panel of small molecules, or metabolites, that appear to indicate aggressive prostate cancer.

Discovery of new prostate cancer marker

Howard Hughes Medical Institute researchers have identified a new biological marker present in the urine of patients with prostate cancer that indicates whether the cancer is progressing and spreading.

New method to stimulate immune system may be effective at reducing amyloid burden in Alzheimer?s

Researchers at NYU Langone Medical Center have discovered a novel way to stimulate the innate immune system of mice with Alzheimer’s disease (AD) - leading to reduced amyloid deposits and the prevention of Alzheimer’s disease related pathology - without causing toxic side effects.

New test for mysterious metabolic diseases developed at Stanford/Packard

Scientists at Stanford University School of Medicine have devised a much-needed way to monitor and find treatments for a mysterious and devastating group of metabolic diseases that arise from mutations in cells’ fuel-burning mechanism.